Antibody drug developer Xoma Corp. would raise $39.2 million by selling nearly 29.7 million shares plus warrants.
Berkeley-based Xoma (NASDAQ: XOMA) on Tuesday priced the common stock and warrants to buy one-half of a share of common stock for each share purchased at $1.32.
No comments:
Post a Comment